DK168571B1 - 4H-[1]-Benzo-(pyrano og thiopyrano)-[3,4-b]pyridiner og salte deraf samt fremgangsmåde til fremstilling deraf - Google Patents

4H-[1]-Benzo-(pyrano og thiopyrano)-[3,4-b]pyridiner og salte deraf samt fremgangsmåde til fremstilling deraf Download PDF

Info

Publication number
DK168571B1
DK168571B1 DK205285A DK205285A DK168571B1 DK 168571 B1 DK168571 B1 DK 168571B1 DK 205285 A DK205285 A DK 205285A DK 205285 A DK205285 A DK 205285A DK 168571 B1 DK168571 B1 DK 168571B1
Authority
DK
Denmark
Prior art keywords
benzopyrano
hydroxy
trans
compound
formula
Prior art date
Application number
DK205285A
Other languages
Danish (da)
English (en)
Other versions
DK205285A (da
DK205285D0 (da
Inventor
Alan Jeffrey Hutchison
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK205285D0 publication Critical patent/DK205285D0/da
Publication of DK205285A publication Critical patent/DK205285A/da
Application granted granted Critical
Publication of DK168571B1 publication Critical patent/DK168571B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06Benzothiopyrans; Hydrogenated benzothiopyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
DK205285A 1984-05-10 1985-05-09 4H-[1]-Benzo-(pyrano og thiopyrano)-[3,4-b]pyridiner og salte deraf samt fremgangsmåde til fremstilling deraf DK168571B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60903784A 1984-05-10 1984-05-10
US60903784 1984-05-10

Publications (3)

Publication Number Publication Date
DK205285D0 DK205285D0 (da) 1985-05-09
DK205285A DK205285A (da) 1985-11-11
DK168571B1 true DK168571B1 (da) 1994-04-25

Family

ID=24439108

Family Applications (1)

Application Number Title Priority Date Filing Date
DK205285A DK168571B1 (da) 1984-05-10 1985-05-09 4H-[1]-Benzo-(pyrano og thiopyrano)-[3,4-b]pyridiner og salte deraf samt fremgangsmåde til fremstilling deraf

Country Status (20)

Country Link
US (1) US4604397A (xx)
EP (1) EP0161218B1 (xx)
JP (1) JPS60243090A (xx)
AR (1) AR243526A1 (xx)
AT (1) ATE64735T1 (xx)
AU (1) AU592308B2 (xx)
CA (1) CA1298582C (xx)
DD (1) DD235872A5 (xx)
DE (1) DE3583307D1 (xx)
DK (1) DK168571B1 (xx)
ES (5) ES8706687A1 (xx)
FI (1) FI83652C (xx)
GR (1) GR851116B (xx)
HU (1) HU199476B (xx)
IE (1) IE57978B1 (xx)
IL (1) IL75135A (xx)
NO (1) NO162860C (xx)
NZ (1) NZ212031A (xx)
PT (1) PT80415B (xx)
ZA (1) ZA853507B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8426584D0 (en) * 1984-10-19 1984-11-28 Beecham Group Plc Compounds
US4666916A (en) * 1985-11-08 1987-05-19 Ciba-Geigy Corporation Hexahydro-(1)-benzo-(pyrano and thiopyrano) (4,3-C)pyridines, useful as serotin-2 blocking agents
US4792548A (en) * 1986-05-21 1988-12-20 Warner-Lambert Company Trans-benzopyran-(4,3-b)-1,4-oxazine derivatives, intermediates and pharmaceutical use
US4801605A (en) * 1986-08-29 1989-01-31 Ciba-Geigy Corporation 3-amino-dihydro-[1]-benzopyrans and benzothiopyrans
FR2619112B1 (fr) * 1987-08-07 1989-11-17 Synthelabo Derives de (piperidinyl-4)methyl-2 benzo(b)furo(2,3-c) pyridines, leur preparation et leur application en therapeutique
US4992465A (en) * 1988-09-27 1991-02-12 Ciba-Geigy Corporation 3-amino-dihydro-(1)-benzopyrans
US5962463A (en) * 1992-10-09 1999-10-05 Massachusetts Institute Of Technology Methods of stimulating non-amyloidogenic processing of the amyloid precursor protein
FR2721027B1 (fr) 1994-06-08 1996-07-19 Adir Nouveaux dérivés tétracycliques de la 1,4-oxazine, leur procédé de préparation et les compositions pharmaceutiques les contenant.
FR2741074B1 (fr) 1995-11-09 1997-12-19 Adir Nouveaux composes tetracycliques de la 1,4-oxazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6342533B1 (en) * 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
WO2000059851A1 (en) * 1999-04-06 2000-10-12 Sepracor Inc. Derivatives of venlafaxine and methods of preparing and using the same
WO2005032485A2 (en) * 2003-10-03 2005-04-14 Psychogenics, Inc. Compounds and methods for the treatment of attention-deficit hyperactivity disorder
WO2007005961A2 (en) * 2005-07-06 2007-01-11 Sepracor Inc. Combinations of eszopiclone and o-desmethylvenlafaxine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
BRPI1003506B1 (pt) 2010-09-24 2019-12-03 Ache Int Bvi Ltd composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143819A (xx) * 1965-09-27
US3514464A (en) * 1967-05-29 1970-05-26 Little Inc A 5-oxo-1,2,3,4-tetrahydro-5h-(1)benzopyrano(3,4-c)pyridines
US3689497A (en) * 1971-03-09 1972-09-05 Warner Lambert Co Substituted benzopyrano (3,4-b) pyridines and process for their preparation
US3915996A (en) * 1972-10-16 1975-10-28 Abbott Lab Process for making benzopyrans
US4025630A (en) * 1973-09-19 1977-05-24 Abbott Laboratories Anesthesia methods using benzopyrans and esters thereof as pre-anesthesia medication
US4292316A (en) * 1978-10-02 1981-09-29 Abbott Laboratories Antiglaucoma agents
US4210758A (en) * 1979-03-21 1980-07-01 Warner-Lambert Company 1,5-Dihydro-1,5-dioxo-N-1H-tetrazol-5-yl-4H-[1]benzopyrano[3,4-b]pyridine-2-carboxamides
US4198511A (en) * 1979-03-21 1980-04-15 Warner-Lambert Company 1,5-Dihydro-1,5-dioxo-N-1H-tetrazol-5-yl-4H-[1]benzopyrano[3,4-b]pyridine-3-carboxamides and process thereof
JPS5746903A (en) * 1980-09-05 1982-03-17 Mitsubishi Chem Ind Ltd Agricultural and gardening fungicide
NL8005754A (nl) * 1980-10-18 1982-05-17 Akzo Nv Benzo 4,5 pyrano 2,3-c pyrrool derivaten.
US4420480A (en) * 1981-11-20 1983-12-13 Merck & Co., Inc. Hexahydronaphth[1,2-b]-1,4-oxazines
US4540691A (en) * 1984-04-13 1985-09-10 Nelson Research & Development Co. Dopamine agonists and use thereof
US4666916A (en) * 1985-11-08 1987-05-19 Ciba-Geigy Corporation Hexahydro-(1)-benzo-(pyrano and thiopyrano) (4,3-C)pyridines, useful as serotin-2 blocking agents

Also Published As

Publication number Publication date
ES542929A0 (es) 1987-07-01
ES555527A0 (es) 1988-01-01
ES555530A0 (es) 1988-01-01
FI83652B (fi) 1991-04-30
CA1298582C (en) 1992-04-07
DK205285A (da) 1985-11-11
DD235872A5 (de) 1986-05-21
GR851116B (xx) 1985-11-25
EP0161218A2 (de) 1985-11-13
PT80415A (en) 1985-06-01
NZ212031A (en) 1988-08-30
NO851846L (no) 1985-11-11
PT80415B (en) 1987-04-16
ES8801279A1 (es) 1988-01-01
IL75135A0 (en) 1985-09-29
FI851802A0 (fi) 1985-05-08
IE57978B1 (en) 1993-06-02
ES8706687A1 (es) 1987-07-01
JPS60243090A (ja) 1985-12-03
DK205285D0 (da) 1985-05-09
US4604397A (en) 1986-08-05
ZA853507B (en) 1985-12-24
AU4224885A (en) 1985-11-14
EP0161218A3 (en) 1987-03-04
JPH0443917B2 (xx) 1992-07-20
FI83652C (fi) 1991-08-12
ES8801280A1 (es) 1988-01-01
ES8801281A1 (es) 1988-01-01
ES555528A0 (es) 1988-01-01
HUT37939A (en) 1986-03-28
DE3583307D1 (en) 1991-08-01
HU199476B (en) 1990-02-28
EP0161218B1 (de) 1991-06-26
NO162860C (no) 1990-02-28
NO162860B (no) 1989-11-20
AU592308B2 (en) 1990-01-11
ES8801282A1 (es) 1988-01-01
IE851155L (en) 1985-11-10
ATE64735T1 (de) 1991-07-15
AR243526A1 (es) 1993-08-31
ES555529A0 (es) 1988-01-01
IL75135A (en) 1989-07-31
FI851802L (fi) 1985-11-11

Similar Documents

Publication Publication Date Title
DK168571B1 (da) 4H-[1]-Benzo-(pyrano og thiopyrano)-[3,4-b]pyridiner og salte deraf samt fremgangsmåde til fremstilling deraf
EP0705832B1 (en) Serotonergic modulators
US4801605A (en) 3-amino-dihydro-[1]-benzopyrans and benzothiopyrans
NO314400B1 (no) Substituerte tricykliske forbindelser
AU596113B2 (en) 3-Amino-dihydro-(1)-benzopyrans and benzothiopyrans
HUT59125A (en) Process for producing pharmaceutical compositions comprising hetercyclic compounds as active ingredient and process for produicng the active ingredients
HU185133B (en) Process for producing 1-hydroxy-octahydro-benzo-bracket-c-bracket closed-quinolines and derivatives
US4666916A (en) Hexahydro-(1)-benzo-(pyrano and thiopyrano) (4,3-C)pyridines, useful as serotin-2 blocking agents
EP0168350B1 (en) Certain ring-fused pyrazolo [3,4-d]-pyridin-3-one derivatives
US4721787A (en) Process for the preparation of benzo-(pyrano and thiopyrano)-pyridines
NO762447L (xx)
US6281216B1 (en) 2-aminoquinoline derivatives having d4-agonistic activity
AU617651B2 (en) Fused benzazepines
EP1213290B1 (en) Dihydrobenzofuran derivatives, process for the preparation thereof and agents
Nicolaides et al. Preparation of 9‐aryl (or heteroaryl) methylidene‐10‐(methoxyimino)‐phenanthrenes and their thermal electrocyclisation to fused quinolines
US4992465A (en) 3-amino-dihydro-(1)-benzopyrans
WO1993008166A1 (en) Benzo-isoquinoline derivatives and analogs and their use in therapeutics
KR20030059140A (ko) 치환된 비페닐 유도체, 이의 제조 방법 및 이를 함유하는약제 조성물
RU2267485C2 (ru) Производные 3-аминометилхинолона-2 в качестве ингибиторов no-синтетазы и способ их получения, биологически активные соединения и фармацевтическая композиция на их основе

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed